Wall Street Just Voted on POET — and the Vote Was 2X Long

On May 1, 2026, Defiance ETFs announced the launch of the Defiance Daily Target 2X Long $POET ETF (CBOE: POEL)— the first leveraged single-stock ETF in the market designed to deliver 200% of the daily price performance of POET Technologies Inc. (NASDAQ: POET).

For anyone who's watched POET's tape over the past several months, this is a moment worth pausing on. Because here's the part that doesn't get said often enough in the financial press:

ETF issuers don't wrap leveraged products around companies they think are fraudulent, terminal, or structurally broken. They wrap them around tickers they expect retail and active traders to want exposure to — repeatedly, at scale, on both sides of the tape.

$POEL exists because somebody at Defiance — and the legal, compliance, and capital-markets infrastructure behind them — looked at POET and concluded the name has the trading volume, the volatility profile, the institutional sponsorship, and the durable retail interest required to support a 2X product. That's not a casual conclusion. That's a due-diligence outcome.

What POEL Actually Is

The Defiance Daily Target 2X Long POET ETF seeks to deliver, before fees and expenses, two times (200%) the daily percentage change in the share price of POET Technologies, through swap agreements and options contracts referencing the underlying.

Per the launch materials, POEL is built strictly for short-term, tactical use by knowledgeable investors who understand leverage, compounding decay, and the difference between daily-rebalanced exposure and a long-term holding. Like every product in Defiance's leveraged single-stock lineup, it's explicitly not a buy-and-hold instrument — it's a precision tool for traders expressing a high-conviction directional view inside an ETF wrapper, without needing a margin account.

POEL joins a Defiance roster that already includes leveraged long products on names like MicroStrategy (MSTX), Oracle (ORCX), IREN (IRE), Seagate (STXL), Rocket Lab (RKLX), Oklo (OKLL), and SoundHound (SOUX), and leveraged short products on names like IonQ (IONZ), Palantir (PLTZ), and AMD (DAMD). That's the company POET now keeps on the issuer's shelf.

What This Tells You About POET — and What It Doesn't

Let's be clear about what POEL's existence does and does not prove.

It does not mean POET's stock is going up. POEL is direction-agnostic in terms of issuer intent — Defiance gets paid an expense ratio whether the underlying rips or tanks. The fund is a tool, not a recommendation.

It does mean POET has cleared a meaningful set of operational and market-structure thresholds. To support a 2X single-stock ETF, the underlying generally needs:

• Sufficient daily trading liquidity for the fund's swap counterparties to hedge cleanly

• An active and liquid options market — POEL uses options contracts in addition to swaps

• A volatility profile that makes leverage commercially attractive to active traders

• A market cap and float structure that doesn't break the hedging mechanics

• A regulatory and disclosure track record that doesn't blow up the legal review

You don't get through the prospectus, the swap counterparty negotiations, the listing exchange (CBOE), the adviser's risk committee at Tidal Investments, and the SEC filing process if the underlying is sitting in the "this company might not exist in six months" bucket. That kind of structural skepticism kills products like POEL before they ever hit a press release.

The Recent Selloff — and the Math That Doesn't Add Up

Some of this needs to be said in the context of POET's recent tape. The stock dropped roughly 50% in a week on news that a counterparty canceled a development order with POET. That's a real event and worth taking seriously. It's also a textbook case of a market reaction that priced like a thesis-break when the actual disclosed facts looked far more like a single program adjustment.

Here's the part the tape glossed over: the public disclosure didn't quantify the order's revenue size or its duration.

Investors didn't know if the cancellation was tied to a $X million development engagement, a $Y million milestone-based contract, or something larger. They didn't know if it represented a meaningful slice of POET's pipeline or a small fraction of one customer relationship inside a broader, diversified roster.

Run the math. POET's market cap got cut by roughly $1.5 billion in a week. For that selloff to be fundamentally justified, the canceled order would need to represent something like $1.5 billion in lost discounted future cash flow — orders of magnitude larger than anything that has been disclosed or is plausible from a single development-stage engagement. If the order was, hypothetically, $10 million in size, the rational repricing is a fraction of one percent of market cap, not fifty percent of it.

What you actually saw, in our read, was a volatility event, not a valuation event. POET trades with high beta, an active options market, and a meaningful retail base. Names with that profile cascade. Stop-losses trip, gamma flips, leveraged longs unwind, momentum funds flip from net-long to net-short on the same data point, and a headline that deserves a 5–8% reaction gets a 50% reaction because the trading structure around the stockamplified it.

That structural amplification is, ironically, exactly the same characteristic that makes POET attractive enough to wrap in a leveraged ETF. POEL exists because POET moves. The recent selloff was a particularly violent expression of why POEL exists in the first place.

For a long-term holder, the question isn't "did a counterparty cancel an order" — that's a known fact. The question is "did the enterprise value of POET Technologies, in May 2026, change by $1.5 billion because of it?" Anyone running that math seriously, with public information, has a hard time getting there.

Why the Single-Stock Leveraged ETF Wave Matters Here

Defiance has built its franchise on being a first mover in this category — single-stock leveraged ETFs that give retail traders precise, margin-free exposure to high-volatility growth names. The category itself is a bet on a specific kind of stock: high-conviction, high-volatility, narrative-driven names where active traders want to express views without writing options or borrowing on margin.

Names like MSTR, IONQ, PLTR, OKLO, and now POET share a common DNA — they're stocks where the story drives the trade as much as the financials. POET's story — silicon photonics, the Optical Interposer platform, and AI-infrastructure positioning — is exactly the kind of narrative that attracts the trader cohort Defiance designs for.

In other words: POEL doesn't exist because POET is sleepy. POEL exists because POET is interesting — to traders, to retail, to the kind of investor who reads a press release on Blazar or Starlight and immediately checks the chart.

What Comes Next

A few things to watch:

• AUM and average daily volume in POEL. A leveraged single-stock ETF that gathers assets quickly is a real-time gauge of trader conviction in the underlying. Watch the fund flows.

• Spillover into POET options activity. Because POEL hedges with swaps and options, its launch can meaningfully affect POET's options market — open interest, implied vol, and skew are all worth monitoring.

For shareholders, the headline is simpler. The financial product engineering complex — the part of Wall Street that has to be right about which stocks will sustain leveraged demand for years — just decided POET deserved a seat at that table.

That's not a stock pick. It's a vote of structural confidence. And it's a vote you don't get from skeptics, screeners, or short-term traders. It comes from the part of the market that has to put real capital, real legal review, and real swap counterparty exposure behind its conclusions.

POEL is the market's quiet, formal, prospectus-stamped vote on POET.